Skip to main content

Advertisement

SpringerLink
Log in

RET Germline Mutations in Codon 609 and MEN2A Phenotype: Are They All Created Equal?

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Calva D, O’Dorisio TM, O’Dorisio MS, Lal G, Sugg S, Weigel RJ, et al. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Ann Surg Oncol. 2009;16:2237–44.

    Article  PubMed  Google Scholar 

  2. Machens A, Lorenz K, Dralle H. Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities. J Intern Med. 2009;266:114–25.

    Article  CAS  PubMed  Google Scholar 

  3. Patócs A, Karádi E, Tóth M, Varga I, Szücs N, Balogh K, et al. Clinical and biochemical features of sporadic and hereditary pheochromocytomas: an analysis of 41 cases investigated in a single endocrine centre. Eur J Cancer Prev. 2004;13:403–9.

    Article  PubMed  Google Scholar 

  4. Klein I, Esik O, Homolya V, Szeri F, Váradi A. Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary. J Endocrinol. 2001;170:661–6.

    Article  CAS  PubMed  Google Scholar 

  5. Igaz P, Patócs A, Rácz K, Klein I, Váradi A, Esik O. Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene. J Clin Endocrinol Metab. 2002;87:1994.

    Article  Google Scholar 

  6. Simon S, Pavel M, Hensen J, Berg J, Hümmer HP, Carbon R. Multiple endocrine neoplasia 2A syndrome: surgical management. J Pediatr Surg. 2002;37:897–900.

    Article  CAS  PubMed  Google Scholar 

  7. Fitze G, Schreiber M, Hohenberger W, Hümmer HP, Roesner D, Schackert HK. Interaction of RET proto-oncogene codon 609 mutations with RET haplotypes characterized by c.135G > A alleles modifying MEN 2A or HSCR phenotypes. Am J Med Genet A. 2004;129A:323–5.

    Article  PubMed  Google Scholar 

  8. Mian C, Barollo S, Zambonin L, Pennelli G, Bernante P, Pelizzo MR, et al. Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation. Fam Cancer. (doi:10.1007/s10689-009-9250-z; e-pub ahead of print 28 May 2009).

  9. Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G, et al. Biological properties of RET with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung’s disease phenotype. Cancer Res. 1997;57:2870–2.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General, Visceral and Vascular Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

    Andreas Machens MD & Henning Dralle MD

Authors
  1. Andreas Machens MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henning Dralle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Machens MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Machens, A., Dralle, H. RET Germline Mutations in Codon 609 and MEN2A Phenotype: Are They All Created Equal?. Ann Surg Oncol 17, 331–332 (2010). https://doi.org/10.1245/s10434-009-0752-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0752-6

Keywords

Search

Navigation